evolcSign inStart free
Menu

cAMPfield Therapeutics

Clinical-stage biopharma developing prifemilast, an oral PDE4B inhibitor, for ulcerative colitis and Crohn's disease

San Diego, United StatesFounded 2026campfieldtx.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2026
  • New on EvolcAdded 2026-11-11

About cAMPfield Therapeutics

cAMPfield Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing oral medicines for immune-mediated inflammatory diseases, starting with inflammatory bowel disease. Its lead candidate, prifemilast, is a once-daily oral preferential inhibitor of phosphodiesterase 4B (PDE4B).

The company is advancing prifemilast into global Phase 2 trials in moderate-to-severe ulcerative colitis and Crohn's disease. Mountainfield Venture Partners, a biopharma company creation firm, is listed as a founder and parent organisation. The board includes representatives of Frazier Life Sciences, Forbion and Deep Track Capital.

The company was founded in 2026 and is headquartered in San Diego, California. Its leadership team includes a CEO, a President of R&D and VPs for clinical development, regulatory affairs and program management. Open roles listed include clinical operations and translational medicine positions based in Boston, Massachusetts.

Product: Prifemilast, a once-daily oral preferential PDE4B inhibitor in clinical development for inflammatory bowel disease.

Jobs at cAMPfield Therapeutics

No open positions listed right now.

More biotech & pharma companies

  • Capable Labs

    AI-driven therapeutics developer building peptide and RNA drugs, starting with sleep disorder programs
    United StatesBiotech & pharma
    New on Evolc

  • Cellanome

    Live-cell imaging and single-cell transcriptomics platform for biology research labs and biopharma companies
    United StatesBiotech & pharma
    New on Evolc

  • Cogent Biosciences

    Develops precision therapies for patients with genetically defined diseases, including cancers and rare diseases
    United StatesBiotech & pharma
    New on Evolc

  • Cognitive Research Corporation

    Contract research organization running Phase I-III central nervous system clinical trials for pharma and biotech sponsors
    United StatesBiotech & pharma
    New on Evolc

  • Corcept Therapeutics

    Develops cortisol-modulating medicines for patients with serious diseases
    United StatesBiotech & pharma2 open jobs

  • Countable Labs

    Single-molecule PCR instruments, assays and testing services for genomics and life-science researchers
    Palo Alto, United StatesBiotech & pharma1 open job
    Remote-friendly

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Recruiting

  • GreenhouseMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.